Fortress Biotech, Inc. 13D and 13G filings for Avenue Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-17 4:05 pm Purchase | 2024-04-16 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 47,521 8.000% | 33,533 (+239.74%) | Filing |
| 2023-09-18 5:08 pm Purchase | 2023-09-08 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 13,987 12.100% | 13,987 (New Position) | Filing |